

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 9.92260056 |
| 2 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 9.01535362 |
| 3 | DNA deamination (GO:0045006) | 8.43692641 |
| 4 | cellular response to interleukin-15 (GO:0071350) | 6.43079364 |
| 5 | regulation of activation of Janus kinase activity (GO:0010533) | 5.50017552 |
| 6 | response to interleukin-15 (GO:0070672) | 5.47993847 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.35445012 |
| 8 | T cell migration (GO:0072678) | 5.31427023 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.25907914 |
| 10 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 5.25401699 |
| 11 | regulation of regulatory T cell differentiation (GO:0045589) | 5.24673286 |
| 12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.17778798 |
| 13 | negative regulation of cell killing (GO:0031342) | 5.17778798 |
| 14 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 5.16091913 |
| 15 | regulation of natural killer cell mediated immunity (GO:0002715) | 5.16091913 |
| 16 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 5.06283851 |
| 17 | positive T cell selection (GO:0043368) | 4.92317533 |
| 18 | positive thymic T cell selection (GO:0045059) | 4.88406909 |
| 19 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.85097116 |
| 20 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.84290908 |
| 21 | eosinophil chemotaxis (GO:0048245) | 4.83210433 |
| 22 | pyrimidine nucleoside catabolic process (GO:0046135) | 4.68312229 |
| 23 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.67599805 |
| 24 | activated T cell proliferation (GO:0050798) | 4.55962158 |
| 25 | positive regulation of interleukin-8 secretion (GO:2000484) | 4.51230727 |
| 26 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.49948278 |
| 27 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.49293731 |
| 28 | negative regulation by host of viral transcription (GO:0043922) | 4.48702600 |
| 29 | negative regulation of viral genome replication (GO:0045071) | 4.46423379 |
| 30 | macrophage chemotaxis (GO:0048246) | 4.45744723 |
| 31 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.42761240 |
| 32 | negative T cell selection (GO:0043383) | 4.38968374 |
| 33 | regulation of lymphocyte chemotaxis (GO:1901623) | 4.37328718 |
| 34 | eosinophil migration (GO:0072677) | 4.36803919 |
| 35 | regulation of gamma-delta T cell activation (GO:0046643) | 4.34061258 |
| 36 | positive regulation of B cell differentiation (GO:0045579) | 4.32591731 |
| 37 | positive regulation of cell killing (GO:0031343) | 4.29228187 |
| 38 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.27892577 |
| 39 | regulation of T cell chemotaxis (GO:0010819) | 4.27574034 |
| 40 | positive regulation of T cell chemotaxis (GO:0010820) | 4.27574034 |
| 41 | interferon-gamma production (GO:0032609) | 4.25250700 |
| 42 | regulation of B cell differentiation (GO:0045577) | 4.22311327 |
| 43 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.17396306 |
| 44 | positive regulation of calcium-mediated signaling (GO:0050850) | 4.16398389 |
| 45 | cytolysis (GO:0019835) | 4.16211397 |
| 46 | negative regulation of T cell apoptotic process (GO:0070233) | 4.11961814 |
| 47 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.09384338 |
| 48 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.08134110 |
| 49 | positive regulation of defense response to virus by host (GO:0002230) | 4.05980557 |
| 50 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.04725799 |
| 51 | regulation of cell killing (GO:0031341) | 4.03976435 |
| 52 | * cellular defense response (GO:0006968) | 3.99726472 |
| 53 | lymphocyte chemotaxis (GO:0048247) | 3.99001488 |
| 54 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.92317325 |
| 55 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.77443729 |
| 56 | regulation of T cell tolerance induction (GO:0002664) | 3.76960915 |
| 57 | positive regulation of lymphocyte migration (GO:2000403) | 3.73865086 |
| 58 | thymic T cell selection (GO:0045061) | 3.69675735 |
| 59 | negative regulation of B cell proliferation (GO:0030889) | 3.67474485 |
| 60 | negative thymic T cell selection (GO:0045060) | 3.65210868 |
| 61 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.63210244 |
| 62 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.62783398 |
| 63 | T cell selection (GO:0045058) | 3.56605080 |
| 64 | granulocyte activation (GO:0036230) | 3.56460613 |
| 65 | leukocyte aggregation (GO:0070486) | 3.55927379 |
| 66 | lymphocyte migration (GO:0072676) | 3.55200955 |
| 67 | regulation of interleukin-8 secretion (GO:2000482) | 3.50816399 |
| 68 | positive regulation of tolerance induction (GO:0002645) | 3.45738434 |
| 69 | negative regulation of type 2 immune response (GO:0002829) | 3.42779180 |
| 70 | dendritic cell chemotaxis (GO:0002407) | 3.40130247 |
| 71 | chemokine-mediated signaling pathway (GO:0070098) | 3.37564733 |
| 72 | T cell receptor signaling pathway (GO:0050852) | 3.36779183 |
| 73 | regulation of chronic inflammatory response (GO:0002676) | 3.31461892 |
| 74 | positive regulation of translational initiation (GO:0045948) | 3.29949943 |
| 75 | regulation of lymphocyte migration (GO:2000401) | 3.28416408 |
| 76 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.28148009 |
| 77 | regulation of tolerance induction (GO:0002643) | 3.22121730 |
| 78 | monocyte chemotaxis (GO:0002548) | 3.21906810 |
| 79 | T cell costimulation (GO:0031295) | 3.20477639 |
| 80 | neutrophil activation (GO:0042119) | 3.20122589 |
| 81 | regulation of mononuclear cell migration (GO:0071675) | 3.18261089 |
| 82 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.17855031 |
| 83 | lymphocyte costimulation (GO:0031294) | 3.16467311 |
| 84 | regulation of macrophage chemotaxis (GO:0010758) | 3.16138531 |
| 85 | regulation of calcium-mediated signaling (GO:0050848) | 3.14017613 |
| 86 | positive regulation of T cell migration (GO:2000406) | 3.11704057 |
| 87 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.09089279 |
| 88 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.07656896 |
| 89 | regulation of viral genome replication (GO:0045069) | 3.07369175 |
| 90 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.06601624 |
| 91 | natural killer cell activation (GO:0030101) | 3.02875752 |
| 92 | negative regulation of B cell activation (GO:0050869) | 3.01945271 |
| 93 | regulation of T-helper 1 type immune response (GO:0002825) | 2.97861824 |
| 94 | positive regulation of T cell mediated immunity (GO:0002711) | 2.97582271 |
| 95 | negative regulation of viral transcription (GO:0032897) | 2.97580741 |
| 96 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.95999452 |
| 97 | regulation of T cell migration (GO:2000404) | 2.94284589 |
| 98 | cytidine metabolic process (GO:0046087) | 11.0807727 |
| 99 | cytidine catabolic process (GO:0006216) | 11.0807727 |
| 100 | cytidine deamination (GO:0009972) | 11.0807727 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 8.49044021 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.54267266 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.40471078 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.31243734 |
| 5 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.57151221 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.44195074 |
| 7 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.12494129 |
| 8 | MYB_26560356_Chip-Seq_TH2_Human | 3.01104544 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.87194282 |
| 10 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.83727819 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.78948510 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.54305698 |
| 13 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.43360661 |
| 14 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.39754232 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.35191648 |
| 16 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.28623303 |
| 17 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 2.24710662 |
| 18 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.17638717 |
| 19 | MYB_26560356_Chip-Seq_TH1_Human | 2.10959337 |
| 20 | UTX_26944678_Chip-Seq_JUKART_Human | 2.05617301 |
| 21 | GATA3_26560356_Chip-Seq_TH2_Human | 2.01929191 |
| 22 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.92012278 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.89962439 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 1.86172537 |
| 25 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84052968 |
| 26 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.83327334 |
| 27 | MAF_26560356_Chip-Seq_TH2_Human | 1.78678525 |
| 28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.74339654 |
| 29 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.70709197 |
| 30 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.66653409 |
| 31 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66430499 |
| 32 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.64294088 |
| 33 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.48897864 |
| 34 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.47161809 |
| 35 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.41235407 |
| 36 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.41068382 |
| 37 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.38663361 |
| 38 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.34373081 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.31862519 |
| 40 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.31422653 |
| 41 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.31176514 |
| 42 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.29190790 |
| 43 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.24162197 |
| 44 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.22748835 |
| 45 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.19269989 |
| 46 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.17563216 |
| 47 | SA1_27219007_Chip-Seq_Bcells_Human | 1.17122920 |
| 48 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17054646 |
| 49 | GATA3_26560356_Chip-Seq_TH1_Human | 1.15583338 |
| 50 | SPI1_23127762_ChIP-Seq_K562_Human | 1.15157239 |
| 51 | GATA1_22025678_ChIP-Seq_K562_Human | 1.14957247 |
| 52 | P300_27268052_Chip-Seq_Bcells_Human | 1.14922255 |
| 53 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.14051219 |
| 54 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.08000656 |
| 55 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.05785519 |
| 56 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05759316 |
| 57 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.05252440 |
| 58 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.03434551 |
| 59 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.03351067 |
| 60 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.03030501 |
| 61 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.01311643 |
| 62 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99257992 |
| 63 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.97619865 |
| 64 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.97185238 |
| 65 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.96967955 |
| 66 | * GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96205677 |
| 67 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.95209196 |
| 68 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.94313658 |
| 69 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.93174940 |
| 70 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.93005107 |
| 71 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.92205871 |
| 72 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.92125863 |
| 73 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.91508829 |
| 74 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.90917701 |
| 75 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.90349985 |
| 76 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87935286 |
| 77 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.86825296 |
| 78 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.86237441 |
| 79 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.84496942 |
| 80 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.83044206 |
| 81 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.82734207 |
| 82 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82047697 |
| 83 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.81629773 |
| 84 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.81220351 |
| 85 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.80703961 |
| 86 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.80507635 |
| 87 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79634040 |
| 88 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.79034916 |
| 89 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.78718335 |
| 90 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.78699773 |
| 91 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.78699773 |
| 92 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.78613503 |
| 93 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.78454169 |
| 94 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.76871924 |
| 95 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.76752814 |
| 96 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.75828214 |
| 97 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.74656165 |
| 98 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.72916996 |
| 99 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.72399376 |
| 100 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.71885888 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 6.85433129 |
| 2 | MP0006082_CNS_inflammation | 5.31967693 |
| 3 | MP0003763_abnormal_thymus_physiology | 4.02865976 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.56597442 |
| 5 | MP0009785_altered_susceptibility_to | 3.45672231 |
| 6 | MP0001873_stomach_inflammation | 3.36263892 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.26383610 |
| 8 | MP0009333_abnormal_splenocyte_physiolog | 3.19008194 |
| 9 | MP0001800_abnormal_humoral_immune | 3.10311916 |
| 10 | MP0005025_abnormal_response_to | 3.00462050 |
| 11 | MP0002723_abnormal_immune_serum | 2.83481360 |
| 12 | MP0002420_abnormal_adaptive_immunity | 2.78851338 |
| 13 | MP0001819_abnormal_immune_cell | 2.70291360 |
| 14 | MP0003436_decreased_susceptibility_to | 2.63110988 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.57711961 |
| 16 | MP0001790_abnormal_immune_system | 2.37505315 |
| 17 | MP0005387_immune_system_phenotype | 2.37505315 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.36810662 |
| 19 | MP0002419_abnormal_innate_immunity | 2.29032278 |
| 20 | MP0003866_abnormal_defecation | 2.15189513 |
| 21 | MP0000685_abnormal_immune_system | 2.14866489 |
| 22 | MP0000716_abnormal_immune_system | 2.10504506 |
| 23 | MP0002398_abnormal_bone_marrow | 2.10274265 |
| 24 | MP0010155_abnormal_intestine_physiology | 2.08343150 |
| 25 | MP0000703_abnormal_thymus_morphology | 2.03361547 |
| 26 | MP0002405_respiratory_system_inflammati | 2.02829030 |
| 27 | MP0003724_increased_susceptibility_to | 2.02766154 |
| 28 | MP0003448_altered_tumor_morphology | 1.97033617 |
| 29 | MP0002933_joint_inflammation | 1.90775852 |
| 30 | MP0004947_skin_inflammation | 1.83787921 |
| 31 | MP0002722_abnormal_immune_system | 1.82233195 |
| 32 | MP0000689_abnormal_spleen_morphology | 1.75661647 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.75535608 |
| 34 | MP0003045_fibrosis | 1.74290762 |
| 35 | MP0000858_altered_metastatic_potential | 1.66508524 |
| 36 | MP0002429_abnormal_blood_cell | 1.56819059 |
| 37 | MP0008469_abnormal_protein_level | 1.51548648 |
| 38 | MP0003011_delayed_dark_adaptation | 1.48589367 |
| 39 | MP0001851_eye_inflammation | 1.46633107 |
| 40 | MP0005464_abnormal_platelet_physiology | 1.35211413 |
| 41 | MP0002166_altered_tumor_susceptibility | 1.32682882 |
| 42 | MP0009763_increased_sensitivity_to | 1.29309622 |
| 43 | MP0004782_abnormal_surfactant_physiolog | 1.27109216 |
| 44 | MP0002877_abnormal_melanocyte_morpholog | 1.18761050 |
| 45 | MP0005166_decreased_susceptibility_to | 1.17447512 |
| 46 | MP0010307_abnormal_tumor_latency | 1.17341801 |
| 47 | MP0001533_abnormal_skeleton_physiology | 1.12597811 |
| 48 | MP0002006_tumorigenesis | 1.10969449 |
| 49 | MP0008873_increased_physiological_sensi | 1.08920920 |
| 50 | MP0001986_abnormal_taste_sensitivity | 1.08728321 |
| 51 | MP0001853_heart_inflammation | 1.06862512 |
| 52 | MP0003690_abnormal_glial_cell | 1.04182045 |
| 53 | MP0003183_abnormal_peptide_metabolism | 1.02876938 |
| 54 | MP0004145_abnormal_muscle_electrophysio | 1.02765276 |
| 55 | MP0009764_decreased_sensitivity_to | 1.01849134 |
| 56 | MP0002277_abnormal_respiratory_mucosa | 1.01739242 |
| 57 | MP0009765_abnormal_xenobiotic_induced | 0.96798540 |
| 58 | MP0002998_abnormal_bone_remodeling | 0.95874029 |
| 59 | MP0005310_abnormal_salivary_gland | 0.93220545 |
| 60 | MP0004130_abnormal_muscle_cell | 0.88938905 |
| 61 | MP0004381_abnormal_hair_follicle | 0.88649432 |
| 62 | MP0000920_abnormal_myelination | 0.88137561 |
| 63 | MP0002234_abnormal_pharynx_morphology | 0.79880893 |
| 64 | MP0002693_abnormal_pancreas_physiology | 0.79136829 |
| 65 | MP0005075_abnormal_melanosome_morpholog | 0.78934932 |
| 66 | MP0003075_altered_response_to | 0.78868005 |
| 67 | MP0002019_abnormal_tumor_incidence | 0.78338668 |
| 68 | MP0003786_premature_aging | 0.76346652 |
| 69 | MP0002653_abnormal_ependyma_morphology | 0.76114693 |
| 70 | MP0000465_gastrointestinal_hemorrhage | 0.76038842 |
| 71 | MP0001919_abnormal_reproductive_system | 0.75399399 |
| 72 | MP0002132_abnormal_respiratory_system | 0.74167785 |
| 73 | MP0003300_gastrointestinal_ulcer | 0.72886817 |
| 74 | MP0004510_myositis | 0.70634871 |
| 75 | MP0001905_abnormal_dopamine_level | 0.69287634 |
| 76 | MP0003137_abnormal_impulse_conducting | 0.64967245 |
| 77 | MP0004883_abnormal_blood_vessel | 0.64602276 |
| 78 | MP0005623_abnormal_meninges_morphology | 0.63691860 |
| 79 | MP0003195_calcinosis | 0.63546520 |
| 80 | MP0001663_abnormal_digestive_system | 0.62973611 |
| 81 | MP0002876_abnormal_thyroid_physiology | 0.62620101 |
| 82 | MP0004142_abnormal_muscle_tone | 0.59112851 |
| 83 | MP0001188_hyperpigmentation | 0.54957954 |
| 84 | MP0001765_abnormal_ion_homeostasis | 0.52692672 |
| 85 | MP0002163_abnormal_gland_morphology | 0.50637004 |
| 86 | MP0008875_abnormal_xenobiotic_pharmacok | 0.49194908 |
| 87 | MP0000343_altered_response_to | 0.48139967 |
| 88 | MP0003795_abnormal_bone_structure | 0.47817213 |
| 89 | MP0005377_hearing/vestibular/ear_phenot | 0.47779725 |
| 90 | MP0003878_abnormal_ear_physiology | 0.47779725 |
| 91 | MP0000490_abnormal_crypts_of | 0.47136274 |
| 92 | MP0001727_abnormal_embryo_implantation | 0.46877637 |
| 93 | MP0005390_skeleton_phenotype | 0.46264656 |
| 94 | MP0002332_abnormal_exercise_endurance | 0.45864133 |
| 95 | MP0002168_other_aberrant_phenotype | 0.44914311 |
| 96 | MP0005381_digestive/alimentary_phenotyp | 0.43874798 |
| 97 | MP0003303_peritoneal_inflammation | 0.42491485 |
| 98 | MP0003646_muscle_fatigue | 0.42337368 |
| 99 | MP0005389_reproductive_system_phenotype | 0.40820052 |
| 100 | MP0000604_amyloidosis | 0.40027080 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of T cell number (HP:0011839) | 8.21109041 |
| 2 | T lymphocytopenia (HP:0005403) | 7.52036193 |
| 3 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 6.07244694 |
| 4 | Increased IgM level (HP:0003496) | 6.04177283 |
| 5 | Autoimmune hemolytic anemia (HP:0001890) | 5.72255983 |
| 6 | Abnormality of eosinophils (HP:0001879) | 5.46453793 |
| 7 | Abnormality of T cells (HP:0002843) | 5.46172932 |
| 8 | Autoimmune thrombocytopenia (HP:0001973) | 4.93175196 |
| 9 | Eosinophilia (HP:0001880) | 4.93108068 |
| 10 | Hypoproteinemia (HP:0003075) | 4.78186515 |
| 11 | IgG deficiency (HP:0004315) | 4.72009499 |
| 12 | Abnormality of macrophages (HP:0004311) | 4.49003061 |
| 13 | Aplastic anemia (HP:0001915) | 4.36362874 |
| 14 | Granulocytopenia (HP:0001913) | 4.33455166 |
| 15 | Leukocytosis (HP:0001974) | 4.29179953 |
| 16 | Hemiplegia (HP:0002301) | 4.13884894 |
| 17 | Encephalitis (HP:0002383) | 4.13414743 |
| 18 | Severe combined immunodeficiency (HP:0004430) | 4.09445750 |
| 19 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.08305311 |
| 20 | Meningitis (HP:0001287) | 3.86923395 |
| 21 | Stomatitis (HP:0010280) | 3.85741495 |
| 22 | Recurrent abscess formation (HP:0002722) | 3.82088308 |
| 23 | Abnormality of T cell physiology (HP:0011840) | 3.81089108 |
| 24 | Chronic diarrhea (HP:0002028) | 3.45147010 |
| 25 | Recurrent cutaneous fungal infections (HP:0011370) | 3.44359221 |
| 26 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.44359221 |
| 27 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.37509928 |
| 28 | Myositis (HP:0100614) | 3.33699575 |
| 29 | Combined immunodeficiency (HP:0005387) | 3.32693082 |
| 30 | Hypochromic anemia (HP:0001931) | 3.29466806 |
| 31 | Recurrent bronchitis (HP:0002837) | 3.27927050 |
| 32 | Recurrent fungal infections (HP:0002841) | 3.23853141 |
| 33 | Optic neuritis (HP:0100653) | 3.22199936 |
| 34 | Retrobulbar optic neuritis (HP:0100654) | 3.22199936 |
| 35 | Vasculitis (HP:0002633) | 3.14207973 |
| 36 | Hypoalbuminemia (HP:0003073) | 3.08962464 |
| 37 | Abnormal albumin level (HP:0012116) | 3.08962464 |
| 38 | Agammaglobulinemia (HP:0004432) | 3.08880284 |
| 39 | Eczematoid dermatitis (HP:0000976) | 3.08852586 |
| 40 | Hypergammaglobulinemia (HP:0010702) | 3.04646916 |
| 41 | Gastrointestinal infarctions (HP:0005244) | 3.00860271 |
| 42 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.96592238 |
| 43 | Orchitis (HP:0100796) | 2.92091014 |
| 44 | Joint swelling (HP:0001386) | 2.92049323 |
| 45 | Obstructive lung disease (HP:0006536) | 2.90926972 |
| 46 | Chronic obstructive pulmonary disease (HP:0006510) | 2.90926972 |
| 47 | Recurrent viral infections (HP:0004429) | 2.88159829 |
| 48 | Pustule (HP:0200039) | 2.84573743 |
| 49 | Recurrent bacterial skin infections (HP:0005406) | 2.76521595 |
| 50 | Pulmonary infiltrates (HP:0002113) | 2.70318177 |
| 51 | Thyroiditis (HP:0100646) | 2.68365935 |
| 52 | Recurrent skin infections (HP:0001581) | 2.64529110 |
| 53 | Increased serum ferritin (HP:0003281) | 2.57812995 |
| 54 | Hypoplasia of the thymus (HP:0000778) | 2.54575505 |
| 55 | Gangrene (HP:0100758) | 2.43800506 |
| 56 | Lymphopenia (HP:0001888) | 2.43743568 |
| 57 | Hemoptysis (HP:0002105) | 2.43538931 |
| 58 | Abnormality of the prostate (HP:0008775) | 2.43038084 |
| 59 | Alveolar cell carcinoma (HP:0006519) | 2.42190423 |
| 60 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.41034134 |
| 61 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.41034134 |
| 62 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.35480917 |
| 63 | Panhypogammaglobulinemia (HP:0003139) | 2.34589605 |
| 64 | Chest pain (HP:0100749) | 2.30104285 |
| 65 | Pulmonary embolism (HP:0002204) | 2.29943137 |
| 66 | Lymphoma (HP:0002665) | 2.28602234 |
| 67 | Mediastinal lymphadenopathy (HP:0100721) | 2.26397142 |
| 68 | Anorexia (HP:0002039) | 2.24593168 |
| 69 | IgM deficiency (HP:0002850) | 2.19280525 |
| 70 | Bronchitis (HP:0012387) | 2.16349134 |
| 71 | Ureteral stenosis (HP:0000071) | 2.16012254 |
| 72 | Keratoconjunctivitis (HP:0001096) | 2.15728324 |
| 73 | Urticaria (HP:0001025) | 2.15691160 |
| 74 | Keratoconjunctivitis sicca (HP:0001097) | 2.13872810 |
| 75 | Abnormality of iron homeostasis (HP:0011031) | 2.13269399 |
| 76 | Tetraplegia (HP:0002445) | 2.05908342 |
| 77 | Nasal polyposis (HP:0100582) | 2.03422105 |
| 78 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.03055696 |
| 79 | Periodontitis (HP:0000704) | 2.02796475 |
| 80 | Ureteral obstruction (HP:0006000) | 2.01520811 |
| 81 | Gingivitis (HP:0000230) | 1.99629992 |
| 82 | Increased CSF protein (HP:0002922) | 1.99102373 |
| 83 | Basal ganglia calcification (HP:0002135) | 1.92559771 |
| 84 | Abnormality of the pleura (HP:0002103) | 1.90831091 |
| 85 | Recurrent otitis media (HP:0000403) | 1.89128904 |
| 86 | Skin rash (HP:0000988) | 1.88697337 |
| 87 | Abolished electroretinogram (ERG) (HP:0000550) | 1.85095435 |
| 88 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.84818122 |
| 89 | Abnormality of the common coagulation pathway (HP:0010990) | 1.83545055 |
| 90 | Diplopia (HP:0000651) | 1.83223702 |
| 91 | Abnormality of binocular vision (HP:0011514) | 1.83223702 |
| 92 | Keratitis (HP:0000491) | 1.81918159 |
| 93 | Abnormality of glycolipid metabolism (HP:0010969) | 1.76798090 |
| 94 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.76798090 |
| 95 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.76798090 |
| 96 | Hyponatremia (HP:0002902) | 1.76168543 |
| 97 | Radial bowing (HP:0002986) | 1.74307917 |
| 98 | Abnormality of the nasal mucosa (HP:0000433) | 1.69784077 |
| 99 | Pulmonary fibrosis (HP:0002206) | 1.68080364 |
| 100 | Oral leukoplakia (HP:0002745) | 1.67869125 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 8.95859296 |
| 2 | MAP4K1 | 4.05821105 |
| 3 | KDR | 3.77252150 |
| 4 | TLK1 | 3.22966729 |
| 5 | ITK | 2.99484229 |
| 6 | PIK3CA | 2.83778667 |
| 7 | FES | 2.73287601 |
| 8 | CSK | 2.39375066 |
| 9 | TESK2 | 2.30557261 |
| 10 | GRK7 | 2.25030269 |
| 11 | LCK | 1.93219732 |
| 12 | ZAP70 | 1.84819123 |
| 13 | STK10 | 1.82061561 |
| 14 | BCKDK | 1.79526328 |
| 15 | RIPK4 | 1.72350087 |
| 16 | TNK2 | 1.71951215 |
| 17 | SYK | 1.70949904 |
| 18 | TAOK3 | 1.70018541 |
| 19 | GRK6 | 1.68388610 |
| 20 | BTK | 1.64022948 |
| 21 | JAK3 | 1.52769176 |
| 22 | TGFBR2 | 1.48527343 |
| 23 | PRKCQ | 1.45509579 |
| 24 | KIT | 1.40913679 |
| 25 | MARK3 | 1.36081229 |
| 26 | PRKCH | 1.30037892 |
| 27 | IRAK4 | 1.29875894 |
| 28 | IKBKB | 1.25270315 |
| 29 | TYRO3 | 1.22067990 |
| 30 | IKBKE | 1.16132979 |
| 31 | ADRBK2 | 1.15845084 |
| 32 | BMPR2 | 1.14410121 |
| 33 | LYN | 1.14239647 |
| 34 | JAK1 | 1.05693395 |
| 35 | MAP3K11 | 1.01654872 |
| 36 | TEC | 1.00305400 |
| 37 | HCK | 0.94611614 |
| 38 | TBK1 | 0.93570224 |
| 39 | PIK3CG | 0.88874546 |
| 40 | FYN | 0.86117527 |
| 41 | PIM1 | 0.85057689 |
| 42 | CSF1R | 0.82824460 |
| 43 | TYK2 | 0.82729876 |
| 44 | BLK | 0.81174243 |
| 45 | JAK2 | 0.80662878 |
| 46 | MAP2K6 | 0.79338357 |
| 47 | CAMKK2 | 0.75474674 |
| 48 | MOS | 0.73148574 |
| 49 | RET | 0.73064891 |
| 50 | WNK4 | 0.72132524 |
| 51 | FGFR1 | 0.70593242 |
| 52 | TESK1 | 0.68239990 |
| 53 | PDK1 | 0.66487766 |
| 54 | GRK5 | 0.61844420 |
| 55 | INSR | 0.61407618 |
| 56 | IGF1R | 0.61252805 |
| 57 | MAPK12 | 0.60177192 |
| 58 | EPHB1 | 0.56757928 |
| 59 | PDGFRB | 0.55288250 |
| 60 | MAP3K14 | 0.55022193 |
| 61 | DAPK2 | 0.52491187 |
| 62 | MATK | 0.51546726 |
| 63 | FGR | 0.49022150 |
| 64 | GRK1 | 0.44312369 |
| 65 | LIMK1 | 0.43749920 |
| 66 | DAPK1 | 0.42280654 |
| 67 | MUSK | 0.41591889 |
| 68 | ADRBK1 | 0.41574000 |
| 69 | MAPKAPK3 | 0.41271624 |
| 70 | STK11 | 0.41162460 |
| 71 | EPHA3 | 0.39683188 |
| 72 | MAP2K7 | 0.38089419 |
| 73 | PTK2B | 0.34066882 |
| 74 | PRKCD | 0.33736227 |
| 75 | OXSR1 | 0.33430576 |
| 76 | MST4 | 0.32130811 |
| 77 | NEK6 | 0.31015410 |
| 78 | PRKD2 | 0.29439107 |
| 79 | MAPKAPK2 | 0.28327925 |
| 80 | MAPK11 | 0.27457596 |
| 81 | SRC | 0.27350440 |
| 82 | MAP2K3 | 0.26967903 |
| 83 | BUB1 | 0.26253737 |
| 84 | INSRR | 0.26074730 |
| 85 | PRKCA | 0.25950892 |
| 86 | PRKACA | 0.25223205 |
| 87 | OBSCN | 0.24181060 |
| 88 | PRKD1 | 0.23866682 |
| 89 | CAMK2A | 0.23418861 |
| 90 | MAP3K6 | 0.22398476 |
| 91 | MAP4K2 | 0.20802443 |
| 92 | FRK | 0.19605824 |
| 93 | ABL1 | 0.19520494 |
| 94 | TIE1 | 0.18087615 |
| 95 | MAP2K2 | 0.17847131 |
| 96 | AURKA | 0.14635076 |
| 97 | RPS6KA5 | 0.14475908 |
| 98 | CAMKK1 | 0.14248260 |
| 99 | CDK19 | 0.12125177 |
| 100 | MAPK3 | 0.11583886 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.12213614 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.99812946 |
| 3 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 4.56240426 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.10542056 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 3.93558752 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.49711582 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.17225224 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.65545801 |
| 9 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.53847749 |
| 10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.31287577 |
| 11 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.14868444 |
| 12 | Measles_Homo sapiens_hsa05162 | 2.10660316 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 1.96124254 |
| 14 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.89840083 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.78738206 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.76785003 |
| 17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.74481814 |
| 18 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.70536570 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.66246299 |
| 20 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.61031681 |
| 21 | Malaria_Homo sapiens_hsa05144 | 1.54210134 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.54013950 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.51535891 |
| 24 | Leishmaniasis_Homo sapiens_hsa05140 | 1.46722964 |
| 25 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.46649626 |
| 26 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.32320612 |
| 27 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.29707451 |
| 28 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.29080703 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.27503991 |
| 30 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.24912756 |
| 31 | Salmonella infection_Homo sapiens_hsa05132 | 1.15304134 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.12355469 |
| 33 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.12123384 |
| 34 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.11018776 |
| 35 | Proteasome_Homo sapiens_hsa03050 | 1.07368484 |
| 36 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.01081011 |
| 37 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.97450481 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 0.95772753 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 0.94917124 |
| 40 | Phototransduction_Homo sapiens_hsa04744 | 0.91352843 |
| 41 | RNA polymerase_Homo sapiens_hsa03020 | 0.89333847 |
| 42 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.86977761 |
| 43 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.81948697 |
| 44 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.80118711 |
| 45 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.75120726 |
| 46 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.74768120 |
| 47 | Shigellosis_Homo sapiens_hsa05131 | 0.72260462 |
| 48 | Influenza A_Homo sapiens_hsa05164 | 0.70432270 |
| 49 | Asthma_Homo sapiens_hsa05310 | 0.70142788 |
| 50 | Pertussis_Homo sapiens_hsa05133 | 0.66740605 |
| 51 | Tuberculosis_Homo sapiens_hsa05152 | 0.59166724 |
| 52 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.56432597 |
| 53 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.54446990 |
| 54 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.52361779 |
| 55 | Prion diseases_Homo sapiens_hsa05020 | 0.50153770 |
| 56 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.47943894 |
| 57 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.46267124 |
| 58 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.40374524 |
| 59 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.39698536 |
| 60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.38776632 |
| 61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38503261 |
| 62 | HTLV-I infection_Homo sapiens_hsa05166 | 0.38358338 |
| 63 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.34455463 |
| 64 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.34447151 |
| 65 | Platelet activation_Homo sapiens_hsa04611 | 0.30610974 |
| 66 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.29864662 |
| 67 | Endocytosis_Homo sapiens_hsa04144 | 0.28097415 |
| 68 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.27603959 |
| 69 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.27541324 |
| 70 | Phagosome_Homo sapiens_hsa04145 | 0.27001484 |
| 71 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26818557 |
| 72 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.25437604 |
| 73 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.25002968 |
| 74 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.24946047 |
| 75 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.22451044 |
| 76 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.19797937 |
| 77 | Hepatitis B_Homo sapiens_hsa05161 | 0.17538599 |
| 78 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.15444973 |
| 79 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.14777203 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.12972909 |
| 81 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.11493518 |
| 82 | Hepatitis C_Homo sapiens_hsa05160 | 0.10889309 |
| 83 | Retinol metabolism_Homo sapiens_hsa00830 | 0.10768637 |
| 84 | Olfactory transduction_Homo sapiens_hsa04740 | 0.10243080 |
| 85 | Lysosome_Homo sapiens_hsa04142 | 0.09900171 |
| 86 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.08373261 |
| 87 | Parkinsons disease_Homo sapiens_hsa05012 | 0.08305758 |
| 88 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.08286062 |
| 89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.07714298 |
| 90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.07380758 |
| 91 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.07367696 |
| 92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.07326298 |
| 93 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.06918117 |
| 94 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.06749758 |
| 95 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.04573236 |
| 96 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.04448851 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.04369806 |
| 98 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.03056891 |
| 99 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.02923333 |
| 100 | Sulfur metabolism_Homo sapiens_hsa00920 | -0.0075914 |

